© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
January 21, 2020
Quality, speed, and price has been referred to as the "Unattainable Triangle".
Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.
January 20, 2020
As we head into a new year, Drug Topics® is exploring some of the latest pharmacy trends and how they will shape the industry in the next decade.
Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.
January 17, 2020
Let’s take a look at some of the most common issues pharmacists are facing, as seen recently on Facebook.
Pharmacists can play an integral role in managing patients with psoriasis through medication therapies and lifestyle modifications.
January 16, 2020
Here are 4 pharmacy-related New Year’s resolutions that can help enhance your pharmacy services.
January 15, 2020
The opioid crisis continues to be one of the worst public health crises that the United States has ever seen.
Progress has been made, but there’s still a long road ahead.
January 14, 2020
Optimism is strong around the pharmacy industry as we head into a new decade, and many believe that 2020 is going to be a pivotal year for the industry.
January 13, 2020
Patients with diabetes now have access to more technology than ever before to help them manage the chronic disease, but the devices can be complicated for patients to use.
Here are the top drugs expected to be approved this year.
December 09, 2019
RDTs can improve outcomes and reduce unnecessary antibiotic use.
Results from a poster at ASHP 2019.